Efficacy of Gut-Brain Neuromodulators in the Treatment of Gastroesophageal Reflux Disease
NCT06945237
·
clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
164
Enrollment
OTHER
Sponsor class
Conditions
Gastroesophageal Reflux Disease
Interventions
DRUG:
Flupentixol-Melitracen + Lansoprazole
DRUG:
Lansoprazole and placebo
Sponsor
RenJi Hospital